504 F.Supp.3d 224
S.D.N.Y.2020Background
- WW (formerly Weight Watchers) shifted in 2018 from a seasonal, year-end program-innovation/weight-loss model toward a year‑round wellness strategy aimed at diversifying membership.
- Historically WW derived substantial sign-ups from lapsed (returning) members and routinely launched major program innovations at year‑end to drive Q1 recruitment.
- In 2018 WW rolled out multiple year‑round initiatives; plaintiffs allege management secretly abandoned a "meaningful" year‑end program and remained dependent on lapsed members.
- Artal (a large shareholder) sold ≈14 million WW shares in two secondary public offerings in 2018; plaintiffs contend those sales and related offering materials were misleading.
- After WW lowered 2019 guidance on Feb. 26, 2019, the stock plunged; plaintiffs brought Securities Act and Exchange Act claims based on alleged misstatements/omissions in SPO materials and SEC filings.
- The district court granted defendants’ motion to dismiss under Rules 12(b)(6)/9(b) and the PSLRA, dismissing all claims.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Omission re: continued reliance on lapsed members | Offering materials failed to disclose that WW still depended heavily on recruiting lapsed (returning) members | Offering documents repeatedly disclosed goal to attract both new and returning members and disclosed historical reliance metrics; no concealment | Dismissed — statements read holistically; no actionable omission about reliance on lapsed members |
| Omission re: abandonment of year‑end "meaningful" program innovation | WW had abandoned its historic year‑end innovation (which takes 1–2 years to develop) but failed to disclose that plan change | WW publicly and repeatedly disclosed a strategy to innovate year‑round, reduced seasonality, and actually launched year‑round initiatives in 2018 | Dismissed — documents and public disclosures put investors on notice; no falsity pleaded |
| Scienter (motive/opportunity via insider sales) | Large insider sales (Artal’s SPOs; alleged Hotchkin sales ≈61% of holdings) show motive and raise strong inference of scienter | Sales timing and mechanics negate suspiciousness (Artal sales were months before disclosure; Hotchkin’s transactions were option exercises and contested) | Artal and Hotchkin: pleadings suffice at this stage to infer scienter; Grossman and Debbane: no motive pleaded; overall scienter inadequately pleaded except as to Artal and Hotchkin |
| Section 12(a)(2) — Is Artal a "statutory seller"? | Artal participated in underwriting/consented to offerings and signed related documents; thus it is a seller | Signing or assistance alone is insufficient; plaintiffs must allege direct solicitation or similar conduct beyond signing | Dismissed — plaintiffs failed to allege Artal acted as a statutory seller (signing/assistance insufficient) |
| Janus "maker" issue (Artal liability under §10(b)) | Artal’s large stake, board influence, and involvement made its statements attributable as a maker | Janus requires "ultimate authority" over content/communication; no allegations Artal controlled or authored the offering statements | Dismissed — plaintiffs failed to show Artal had ultimate authority to be a §10(b) maker |
| PSLRA safe-harbor for forward‑looking statements | Statements were forward‑looking but materially false | Statements were identified as forward‑looking and accompanied by meaningful, specific cautionary language; alternately, plaintiffs fail to allege actual‑knowledge falsity | Court finds many challenged statements are forward‑looking and protected by the PSLRA safe harbor (cautionary language was substantive) |
| Loss causation | The February 2019 disclosure revealed the earlier concealment and caused the stock drop | No actionable misstatements/omissions were pleaded, so nothing concealed that could have caused the loss | Dismissed — absent actionable fraud, plaintiffs fail to plead loss causation |
Key Cases Cited
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (plausibility standard for pleadings)
- Ashcroft v. Iqbal, 556 U.S. 662 (pleading standard; draw reasonable inferences)
- Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308 (strong inference of scienter must be cogent and at least as compelling as nonfraudulent inference)
- Amgen Inc. v. Conn. Ret. Plans & Tr. Funds, 568 U.S. 455 (elements of §10(b) claim)
- Janus Capital Grp., Inc. v. First Derivative Traders, 564 U.S. 135 (maker = person with ultimate authority over statement)
- Pinter v. Dahl, 486 U.S. 622 (definition of "statutory seller" under §12)
- Santa Fe Indus., Inc. v. Green, 430 U.S. 462 (securities laws do not reach mere corporate mismanagement)
- Lentell v. Merrill Lynch & Co., 396 F.3d 161 (loss causation requires that the fraud concealed the risk that materialized)
- Rombach v. Chang, 355 F.3d 164 (Rule 9(b) applies to fraud‑sounding Securities Act claims)
- Novak v. Kasaks, 216 F.3d 300 (particularity requirements for CW allegations)
- Kalnit v. Eichler, 264 F.3d 131 (requiring strong inference of scienter)
- Slayton v. Am. Express Co., 604 F.3d 758 (PSLRA safe harbor and meaningful cautionary language)
- Halperin v. eBanker USA.com, Inc., 295 F.3d 352 (bespeaks‑caution and immateriality doctrines)